Literature DB >> 20548225

Influence on the osteogenic activity of the human bone marrow mesenchymal stem cells transfected by liposome-mediated recombinant plasmid pIRES-hBMP2-hVEGF165 in vitro.

Wu Guo-ping1, He Xiao-chuan, Yang Zhi-hui, Guo Li.   

Abstract

Bone marrow mesenchymal stem cells (BMSCs) is an attractive option for use as seed cells in tissue engineering strategies. Bone morphogenetic proteins (BMPs) to be involved in the formation of various tissue types including bone, cartilage, tendon, and ligament. Vascular endothelial growth factor (VEGF) is a promising reagent for inducing angiogenesis. Constructed a coexpressing vector of human bone morphogenetic protein 2 (hBMP-2) and vascular endothelial growth factor 165 (hVEGF165). The vectors were transfected into proliferated BMSCs isolated from healthy adult bone marrow. The expression of hBMP-2 and hVEGF165 genes of BMSCs were assayed by Western-blot, and the level of alkaline phosphatase activities of BMSCs was determined by RT-PCR analysis of osteocalcin mRNA expression. The levels of collagen I by immunohistochemical staining were also determined.BMSCs transfected with reconstructed plasmid pIRES-hBMP-2-VEGF165 could secret a high level of BMP-2 and hVEGF165. The production of type I collagen, the activity of alkaline phosphatase, and the expression of osteocalcin mRNA were also significantly improved in the transfected BMSCs, compared with the control group.The exogenous hBMP-2 and hVEGF165 genes can be expressed constitutively in the transfected BMSCs, and the lineage-committed differentiation abilities of BMSCs containing combination of genes BMP-2 and VEGF165 are enhanced.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20548225     DOI: 10.1097/SAP.0b013e3181b4bc5d

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  7 in total

1.  VEGF(165) expressing bone marrow mesenchymal stem cells differentiate into hepatocytes under HGF and EGF induction in vitro.

Authors:  Yan Tan; En-Hua Xiao; Li-Zhi Xiao; You-Hong Yuan; Cong Ma; Quan-Liang Shang; Du-Jun Bian; Yan-Hui Li; Zhu Chen; Qian Chang
Journal:  Cytotechnology       Date:  2012-04-04       Impact factor: 2.058

Review 2.  Liposomes in tissue engineering and regenerative medicine.

Authors:  Nelson Monteiro; Albino Martins; Rui L Reis; Nuno M Neves
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

3.  Experimental construction of BMP2 and VEGF gene modified tissue engineering bone in vitro.

Authors:  Jia Jiang; Cun-Yi Fan; Bing-Fang Zeng
Journal:  Int J Mol Sci       Date:  2011-03-07       Impact factor: 5.923

Review 4.  Musculoskeletal tissue engineering: Adipose derived stromal cell implementation for the treatment of osteoarthritis.

Authors:  R Tevlin; H desJardins-Park; J Huber; S E DiIorio; M T Longaker; D C Wan
Journal:  Biomaterials       Date:  2022-05-06       Impact factor: 15.304

Review 5.  Non-viral Gene Delivery Methods for Bone and Joints.

Authors:  Benjamin Gantenbein; Shirley Tang; Julien Guerrero; Natalia Higuita-Castro; Ana I Salazar-Puerta; Andreas S Croft; Amiq Gazdhar; Devina Purmessur
Journal:  Front Bioeng Biotechnol       Date:  2020-11-19

6.  Effects of BMP2 and VEGF165 on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells.

Authors:  Zhaowei Lin; Jiang-Sheng Wang; Lijun Lin; Jingwen Zhang; Yunlong Liu; Ming Shuai; Qi Li
Journal:  Exp Ther Med       Date:  2013-12-27       Impact factor: 2.447

7.  A comparative study of non-viral gene delivery techniques to human adipose-derived mesenchymal stem cell.

Authors:  Nur Shuhaidatul Sarmiza Abdul Halim; Kamal Shaik Fakiruddin; Syed Atif Ali; Badrul Hisham Yahaya
Journal:  Int J Mol Sci       Date:  2014-08-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.